For a localized hidradenocarcinoma of the extremity managed with resection, what adjuvant dose to the surgical bed would you recommend?
Would this recommendation change based on proximity to a joint?
Answer from: Radiation Oncologist at Academic Institution
Hidradenocarcinoma is an extremely rare pathologic condition. Over the past five years I have treated many patients with hidradenitis suppurativa with surprisingly good results, but I have yet to see a malignancy arising in any of these areas. My advice would be to treat these patients as you would ...
Comments
Radiation Oncologist at Bon Secours Mercy Health Thank you for you help and input. What would be yo...
Radiation Oncologist at University of Oklahoma College of Medicine Usually not because of increased morbidly. Let the...
Thank you for you help and input. What would be yo...
Usually not because of increased morbidly. Let the...